Nicholas Robbert Vorhoff - 08 Mar 2022 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Reporting relationship: Director
Issuer ticker: ALHC
Reported as of: 08 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Mar 2022, 16:18:11 UTC
Prior SEC filing: 31 Aug 2021
Next SEC filing: 10 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Richard A. Cross, as Attorney-in-Fact, for Nicholas Robbert Vorhoff

Key filing fact

Nicholas Robbert Vorhoff filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 10 Mar 2022.

Key facts

This page summarizes Nicholas Robbert Vorhoff's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Mar 2022, 16:18.

Change

Previous filing in this sequence was filed on 31 Aug 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALHC transaction

Common Stock

Award

Transaction value: $0
Shares: +16,556
Change %: +50%
Price: $0.000000
Shares after: 49,379
Date: 08 Mar 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents 16,556 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares until separation of service as a director (or, if earlier, until a change of control of the Company).